wentworth. >> interesting pick. veteran of cigna, a veteran of express scripps. >> he's what we call money. he's fantastic. now, they report tomorrow -- i don't think they do a good number. that's ridiculous. he's from the health care side. it's only about $6 billion versus the $100 billion pharmacy but how about if you closed all the places where stealing is rife because there's under a thousand dollars you can steal? well, then, i think you'd have a really good company. i think it could be a really good health care company, so i'm very positive on walgreens. i'm not negative on pioneer. i just got to move on. i was hoping to get a higher price, but that's okay. everybody wants a higher price. >> are you saying you're specifically looking for m&a in oil or beyond energy? >> i think coterra -- i think jordan's doing a fantastic job, but the fact that the stock's at $28 is absurd. they've got the next best permian and the best nat gas so i i'n ugly "w" but it's a "w." >> to your point, carl, we've seen two large deal

walgreens is announcing that veteran health care executive tim wentworth will be its new ceo. the board wanted someone with deep health care experience and went woct had that. he was a ceo of a company acquired by cigna in 2018. he stayed on and served as head of cigna's health services division and then retired in 2021. now, wentworth told me that the chance to lead an iconic brand like walgreens lured him back to the c-suite. he said it's a massive platform. that i touch almost 10 million people a day. it needs someone that can come in tand take the great team tha they have. the announcement comes five days after roz brewer stepped down. le there was home care and others that pressured profits at a time when covid sales have lagged. last quarter walgreens earnings missed for the first time in three years. tomorrow wentworth gets a frommer start with the new fiscal year. he starts on october 23rd. frank? >> bertha, thank you very much. our bertha coombs with that market flash. again, walgreens shares moving 1% higher. >>> our weeklong series, diving sectors and rising rates,

analyst say commences a new era for shares of wba as tim wentworth assumes the ceo role, no pressure, up nearly 4%, sales force heading in the other direction after 5% cutting the rating on the stock from overweight to neutral, the investment bank cut its price target from $268 to 232 saying the club-based companies 2024 growth estimate appear too high as the company shifts to prioritizing testing generative a.i. features down about a half 8%, bitcoin hitting a three month high as a crypto flirts around the 31000 mark, has not been there a while, it also helped ethereum and xp are prompting morgan stanley of the crypto winter may be over in crypto spring may be on the horizon. i guess time will tell, the israeli hamas war expanded as hundreds of airstrikes prep the stage for is it really ground war, it's all going on as hundreds of hostages are being held in gaza. a live update on the military situation, we're going to talk to one woman who had five relatives take hostage. defense stocks with a mixed picture boeing and general dynamics, lockheed martin hi higher, rtx corporation sligh

tim wentworth talked about that. they pivoted amazingly and very quickly to sort of providing all of these services during covid. they were the front line to get us those tests, those shots. now he says that needs to be re-evaluated a bit and they need to be given more room and leeway to really practice at the top of their licenses. but, you know, this is something that all of the major chains have been grappling with, cvs as well as walgreens because they're such a big point of interest. certainly -- i don't know about you, becky, but every time oi go to the pharmacy, there's just such a long line, and i feel for these workers because they have a lot on their plates. >> yeah. they seem pretty busy every time i'm there too. thank you very much. >>> meantime we're watching shares of novo nordisk after they said they will stop a trial study of ozempic nearly a year ahead of schedule because it was so successful. that was good news. they were testing whether ozempic could delay the risk of chronic kidney disease and dia

you like wentworth. would you buy the stock? >> it's 77% off its all-time high.ou know, i have to question my buy rating on this, but that's like signing tom brady. he was at pepsi, mary kay. express scripts. he's a stud. i think you're seeing some investor appetite. if you want to be careful, approach this long you can sell puts here. you can buy upside calls. when you look at historical valuation, the forward pe ratio has been 5 1/2 up to nearly 12. that's the average. right now it's trading at six times forward p/e. i think it's on the bottom. i want to be a buyer here. tim wentworth is a stud. >> a trifecta in the morning. your two cents on bond yields at this point. we did see them touch lows earlier in the session and move a little bit higher. do you think that's putting pressure on the market? >> you know, we talked about yields about a week ago and i was a believer when it was -- that we would sigh 5% by 4%. we had no idea that we would see the atrocities in the middle east. i think you're seeing people covering their trades. it's the beauty of a big hedg

i don't know if wentworth can truly change the stores.be the whole place should just be one endless line of vending machines! anyway, the health care business is not an afterthought. that's why i think walgreen's is a good buy even though i can only wonder how the -- do not forget, walgreen's wholeheartedly embraced theranos before it was revealed as a total fraud. now we're on the eve of the banks reporting and i think these companies are already defrocked, derisked, whatever you want to say. bank of america which sells at eight times earnings slink down to seven? i'm not sure. but i know it has more room to run if the reports say anything good. we're partial to wells fargo for the charitable trust which is coming in at a blistering eight times earnings. with a 3.5% yield. if ceo charlie scharf can say anything positive at all i think the stock can jump. the problem is that pesky yield curve. we know the bond market wrecks the banks at every turn. clubbing them like -- you know what i say. that's it. we have to be wary of being too negat

morgan says buy them there entering a new era for shares, the new ceo tom wentworth takes a corner office healthcare experience, walgreens is printed onto healthcare. stuart: so far this year the announcement of the seo was made walgreens has done very well. >> it's down 43%, awful earnings but they see this as being a turnaround. stuart: i understand pfizer is selling off on part of the company one division, which division. >> rosh which is a swiss company $7.1 billion to pfizer and drove yet vivek ramaswamy's for the disease start. this is beyond cancer. stuart: ramaswamy emerges with a lot more money, yes money in that company. maria: he stepped away because he is running for president. >> i'm sure he has an ownership stake and now more valuable ownership stake. we would have to declare that. and that company likes to take drugs that appear to be popular in late phase trials that are seen success in the market and commercialize them. stuart: pfizer is at $30 a share, the pandemic at 50, i will always remember that. check the big board, six minutes we are down 180, that is more than a h

half a percent and pets will take over for current chairman and ceo and wall greens announcing tim wentworths the nod in a week. he's going to join the board of directors and last role was founding ceo of evernorth, cigna health organization and partners and walgreens up 1.25%. let's talk about kansas city kava hot ipoand morgan stanley m equal right to overweight. investment bank cut price target on mediterranean chain from $45 down to $41. it's at $32.35. they went public in june with a price of $22. the stock zoomed higher, peaked at 57 in july and lost more than half those gains. ozempic continuing to ex-cede expectations. the maker of the weight loss drug and diabetes drug said a trial has shown enough science of success in delaying progression of kidney disease in diabetes patient sos much so it'll end the study early and full results expected durck the first half of 2024. novonortis is good news. the kidney front pushing vieder has bad news and outset and all three moving lower from 17% to 21. call it 22% for outset medical. traders, look at this on the new york stock exchange floor,

wentworth starts his job a week from monday >> this guy's a genius. >> you said nice things yesterday>> he's powerful, and he understands. the previous ceo left before the press release was out. suboptimal. this fellow -- i sound like my father -- is so good. what a choice. i love it. >> we'll talk more about that, obviously. it's a big corporate management piece right now. >>> the market's still fielding headlines from the israel-hamas war. now entering its sixth day. we got the secretary of state arriving in tel aviv today, meeting with regional leaders, including netanyahu. kelly cobiella is live on the ground this morning. good morning. >> reporter: good morning, carl. yeah, the government here in israel is not yet announced any sort of ground offensive. they haven't officially said they're going in on the ground, but that is clearly the direction we're headed, and it could come -- when you look at the number of troops and tanks amassed on the ground at the border with gaza, more than 300,000 reservists, some coming in from abroad, getting ready, preparing for war, for what will b

w wentworth has a history of execution, i mean, everyone knows that the pharmacy side sucks, the retailations around walgreen's alliance right now is going to be coming from the health care services side of the business. if you really focus on the health care service side of the business, they've lost over $600 million year-to-date off of poor strategy execution. it's like the opposite of the field of dreams. you know, they built these village facilities, but really, no one really came, so i'm really not interested in owning a business that has, you know, struggling on the retail side and on the pharmacy side combined with a third leg of the business really that has had really poor execution on the services side. i'm staying away here. >> all right, let's see what you think about target. they're saying the shares, which we know have been under a lot of pressure now look attractive while margins could you've in the y-- improve in the year ahead. >> i'm begrudgingly saying investors could dip their toes in this thing. i'm not going to say the all clear sign is out there. the stock's still

a new ceo, tim wentworth with, he replaces rosalynn brewer.ts, and walgreens is pushing deeper into health care, so i guess that marriage is favorable. stuart: and what's he going to do about shrink shrinkage? lauren: i was reading a story the other day, or when you check yourself out at the self checkout, it's still easy to steal, it really is. a lot of stores are noticing that, so they're starting to get rid of some of the self checkouts. stuart: are they really? lauren: yeah. you check yourself out and you're stealing and you condition get your items because other people have to go behind lock and key. stuart: birkenstock. i know a few things about them, they are a boot -- shoe manufacturer. [laughter] they debut today -- lauren: how much do you think that costs? that sandal? stuart: probably at least $100. lauren: i think it's 120. stuart: a bargain. stuart: and so the is the stock. valuation, $8.6 billion. i did not though that birkenstocks have been around for 250 years. stuart: really? lauren: that 25 years. but guess who made them supe

new ceo tim wentworth begins his tenure later this month. >> more job cuts are on the way for bay area based linkedin. the professional networking site is laying off 668 workers. that's on top of 716 workers who were laid off in may. the new job cuts represent 4% of linkedin's workforce. the company is owned by microsoft but is based in sunnyvale. linkedin is also subleasing its san francisco office in the north bay. >> a meeting is underway right now that could determine if teachers in the sausalito marin city school district will go on strike. members authorized a strike last month. today, the union and district are presenting their contract proposals to a three member panel that will then make a recommendation for an agreement if no deal can be reached, the union could call a strike bomb threats shut down several bay area schools today. stratford schools in fremont and dublin closed for the day after receiving an email claiming there were explosives on campus. dublin police checked the campus with bomb sniffing dogs as the staff waited outside. nothing turned up, thankfully, in any

new ceo tim wentworth begins his tenure later this month. >> taylor swift's concert movie was the box weekend. taylor swift, the eras tour took in more than $96 million in its opening weekend in seven out of every ten movie tickets sold in north america this weekend were for her movie. and it was an event. people got dressed up and even exchanged friendship bracelets, just like at the concert. check out our producer's cousin, olivia lopez with her stack of bracelets. looks good. eras isn't the only major music tour with a movie version. renaissance announce a film by beyonce chronicling the tour that drew 2.7 million fans, opens december 1st. >> well, coming up next, the newest trend in farming. we're talking about kelp grown right off california's coast. >> and we'll get a look at the weather for the week ahead, see what to expect in sandy's seven day forecast time to win is running out in our prize packed kick off the savings monopoly game! hurry in to play for your chance at over $25 million in prizes and money saving offers like this, and this, or even this. plus, you still have a

it comes two days after the company named tim wentworth as its new ceo.k since november. back to you. >>> last chance now to weigh in on our question of the day. we asked will the s&p 500 be higher or lower one month from today once earnings season is all but over, you can head to @cnbc closing bell on x, the results just after this break. what do you see on the horizon? uncertainty? or opportunity. whatever you see, at pgim we can help you rise to the challenges of today, when active investing and disciplined risk management are needed most. drawing on deep expertise across the world's public and private markets in pursuit of long-term returns... pgim. our investments shape tomorrow today. (swords clashing) -had enough? -no... arthritis. here. aspercreme arthritis. full prescription-strength? reduces inflammation? thank the gods. don't thank them too soon. kick pain in the aspercreme. i promise - as an independent advisor - to put the financial well-being of you and your family first. i promise to serve, not sell. i promise our relationship will be one o

it comes as the new ceo, tim wentworth, begins his tenure later this month.company says they are expecting to cut out $1 billion in costs in 2024. and now we take a live look at the new york stock exchange as trading gets underway this morning. you can see that we're up about 240 points. >> movie theaters became concert venues over the weekend as swifties showed up for the new taylor swift movie, the heiress tour film swifties broke records in attendance coming in first place in north america. critics say it's easily the biggest opening for a concert film of all time. so far, it's made more than the 73 million, more than $73 million. and it is on pace to beat the biggest october opening ever, which was joker in 2019. there was a surprise trailer in theaters for anyone who saw the heiress tour film. >> the first trailer for the mean girls musical movie debuted the trailer hasn't actually been officially released online, but some fans took video in the theater of the 32nd trailer, and it shows the burn book, the iconic christmas talent show scene, a cameo by cr

she's talking about wentworth being a smart health care guy.ot to get out of the shoplifting business and get in the money business. that shoplifting per share has got to go away. >> they call it a clearable bar as this new management rolls in. >> when they give away the chocolate at the front of the store because they know that therefore they can say, look, here, an offering, that's got to go away too. you should charge. i find charging to be an incredibly positive experience. >> it's a very helpful way to make money. >> there was a great piece in "the atlantic" about self-checkout being a failure. i said, maybe they don't use the self-checkout because it's such a pain, they just walk out. >> you can pretend to use the self-checkout. you can sort of do, you know -- >> have you ever done that? >> no. >> bay mistake? costco says there's a lot of people who do it by mistake. they thought they paid. that's why they have to have people. >> they didn't have the receipt. >> right, but this is the problem with shelf-checkout. cvs and walgreens continu

a kitchen sink quarter here as new ceo tim wentworth will start on october 23rd. becky?uch. >>> we have seen that stock down pretty significantly, down about 42% year to date. expectations for ty have a lot to rein in the costs. think about the fact they're going to be lapping now, you know, a lot of those big payments as well for opioid litigation. that also ate into operating profits. so, they are trying to sort of right size their costs. but when it comes to labor, they're going to have to really look at that. they can't afford to at this point make cuts on that end. they're talking more about the health unit, where they're trying to rein in the costs to get that to break even. their expectation is they'll get that to break even sometime this year, fiscal 2024. >> bertha, thanks. >>> right now over to dom chu, he's got a look at this morning's stocks to watch. dom, good morning. >> we got an interesting theme here, becky. the stocks to watch this morning is going to focus on the consumer. starting with the drop right now and shares of domino's pizza, lower on thinner